首页> 外国专利> Combined use of bispecific antibodies and immunologic drugs corresponding to BCMA and CD3 for the treatment of multiple myeloma

Combined use of bispecific antibodies and immunologic drugs corresponding to BCMA and CD3 for the treatment of multiple myeloma

机译：结合使用双特异性抗体和对应于BCMA和CD3的免疫药物治疗多发性骨髓瘤

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to bispecific antibodies that specifically bind to human B cell matured antigens (BCMA) and human CD3 [epsilon] together with immunological drugs for the combined use in the treatment of multiple myeloma.

机译：本发明涉及特异性结合人B细胞成熟抗原（BCMA）和人CD3ε的双特异性抗体，以及结合用于治疗多发性骨髓瘤的免疫学药物。

著录项

公开/公告号KR20190086477A

专利类型
公开/公告日2019-07-22

原文格式PDF
申请/专利权人 잉맵 에스에이알엘;
展开▼

申请/专利号KR20197015708
发明设计人 브이유 민 데임;스트레인 크라우스;파이바 브루노 데이비드 로렌코;산 미구엘 이즈퀴어도 지저스 페르난도;
展开▼

申请日2017-11-02
分类号C07K16/28;A61K39;A61P35;C07K16/46;
国家 KR
入库时间 2022-08-21 11:50:21

相似文献

专利
外文文献
中文文献